Healthconn Corp. (TPEX:6665)
Taiwan · Delayed Price · Currency is TWD 20.40
-0.10 (-0.49%)
At close: Feb 11, 2026
Healthconn Revenue
Healthconn had revenue of 547.94M TWD in the half year ending June 30, 2025, a decrease of -11.72%. This brings the company's revenue in the last twelve months to 1.20B, down -2.29% year-over-year. In the year 2024, Healthconn had annual revenue of 1.25B, down -0.20%.
Revenue (ttm)
1.20B
Revenue Growth
-2.29%
P/S Ratio
0.77
Revenue / Employee
5.87M
Employees
205
Market Cap
925.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.25B | -2.51M | -0.20% |
| Dec 31, 2023 | 1.26B | -289.50M | -18.73% |
| Dec 31, 2022 | 1.55B | 182.35M | 13.38% |
| Dec 31, 2021 | 1.36B | -144.18M | -9.57% |
| Dec 31, 2020 | 1.51B | -457.46M | -23.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Concord Medical | 905.31M |
| Taiwan Advance Bio-Pharmaceutical | 371.86M |
| TCI GENE | 324.73M |
| S&S Healthcare Holding | 205.64M |
| NatureWise Biotech & Medicals | 180.29M |
| AmCad BioMed | 43.51M |